Mark Leonard Singleton Bioventus Inc. (BVS) insider trading activity

Mark Leonard Singleton is SVP & CFO of Bioventus Inc.. Currently has a direct ownership of 131,963 shares of BVS, which is worth approximately $1.28 Million. The most recent transaction as insider was on Mar 24, 2025, when has been sold 5,479 shares (Class A Common Stock) at a price of $9.79 per share, resulting in proceeds of $53,639. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K

25.49% 3M change

414.17% 12M change

Total Value Held $1.28 Million

Mark Leonard Singleton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 24 2025	SELL Open market or private sale	$53,639 $9.79 p/Share	5,479 Reduced 3.99%	131,963 Class A Common Stock
Mar 21 2025	BUY Exercise of conversion of derivative security	-	18,625 Added 11.93%	137,442 Class A Common Stock
Feb 18 2025	SELL Open market or private sale	$66,214 $10.19 p/Share	6,498 Reduced 5.19%	118,817 Class A Common Stock
Feb 15 2025	BUY Exercise of conversion of derivative security	-	20,153 Added 13.85%	125,315 Class A Common Stock
Dec 23 2024	SELL Open market or private sale	$113,018 $10.53 p/Share	10,733 Reduced 9.26%	105,162 Class A Common Stock
Dec 20 2024	BUY Exercise of conversion of derivative security	-	31,000 Added 21.1%	115,895 Class A Common Stock
Jun 21 2024	SELL Open market or private sale	$51,349 $5.57 p/Share	9,219 Reduced 9.8%	84,895 Class A Common Stock
Jun 20 2024	BUY Exercise of conversion of derivative security	-	31,000 Added 24.78%	94,114 Class A Common Stock
Jun 17 2024	SELL Open market or private sale	$80,317 $5.84 p/Share	13,753 Reduced 17.89%	63,114 Class A Common Stock
Jun 15 2024	BUY Exercise of conversion of derivative security	-	42,202 Added 35.44%	76,867 Class A Common Stock
Apr 11 2024	SELL Open market or private sale	$19,000 $4.75 p/Share	4,000 Reduced 10.35%	34,665 Class A Common Stock
Apr 10 2024	BUY Exercise of conversion of derivative security	-	13,000 Added 25.16%	38,665 Class A Common Stock
Mar 22 2024	SELL Open market or private sale	$29,865 $5.39 p/Share	5,541 Reduced 17.76%	25,665 Class A Common Stock
Mar 21 2024	BUY Exercise of conversion of derivative security	-	18,625 Added 37.38%	31,206 Class A Common Stock
Mar 24 2023	SELL Open market or private sale	$7,675 $1.27 p/Share	6,044 Reduced 32.45%	12,581 Class A Common Stock
Mar 21 2023	BUY Exercise of conversion of derivative security	-	18,625 Added 50.0%	18,625 Class A Common Stock

MLS

Mark Leonard Singleton

SVP & CFO

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BVS shares.

Notify only if

Value

Insider Trading

Get notified when an Bioventus Inc. insider buys or sells BVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Bioventus Inc.

Track Activities on BVS

Account